| News
Patients stand to benefit from innovative tech project
11.12.2020
The investment and innovation promotion agency Basel Area Business & Innovation is joining forces with several partners to realize a technology project. For this, an app aimed at supporting oncology patients is being developed.

Version under development of the app for patients of the Hospital of Jura
The Hospital of Jura (H-JU) will be realizing four joint projects together with Basel Area Business & Innovation over the next four years. For the first, the two partners have also brought on board the University Hospital Basel (USB) and Haute Ecole Arc (HE-Arc). For this inter-cantonal technology project, an app is being developed for oncology patients. This is aimed at providing an improved overview of upcoming doctor’s appointments and treatments for users. The Swiss federal government and the canton of Jura have provided financial backing for the project, as detailed in a press release.
The patients in question from the canton of Jura are being treated at either the H-JU in Delémont or the USB in Basel. For this reason, an overview of appointments as well as information on the various institutions is important for the patients. The app should not only display these appointments and remind users of these, but will also be shared with other relatives. In addition, any entries and notifications about prescribed medication and treatments can be accessed here. The new app is rounded off by providing further information on the respective illness. In this way, individual information can be sent to the patient, which should also lead to faster reactions.
Basel Area Business & Innovation is the initiator of the project and will also be responsible for coordinating it. Given that the relevant pre-planning has already been carried out with developers, software ergonomics specialists and engineering students from HE-Arc at Switzerland Innovation Park Basel Area in Courroux in the canton of Jura, the test phase is set to begin before the end of this year. In a next step, a company from Jura will be tasked with developing a marketing concept. In future, the app should be available for other hospitals and medical practices, including for other medical disciplines.
Share this article
Sign up to receive our newsletter in your inbox.
You may also be interested in
VectivBio sold for approximately 1 billion dollars
The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...
Read MoreUniversity of Basel and RocketVax present new Covid vaccine
Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...
Read MoreRami Swiss and Elbit Systems now manufacturing in Jura
The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...
Read MoreBasel to become Europe’s Silicon Valley of biotech
Silicon Valley is synonymous with technology and innovation, and home to dozens of Fortune 1000 companies and thousands of startups....
Read MoreRoche and Novartis among global leaders for research spending
In 2022, Roche invested 16 billion euros in research and development overall. This puts the Basel-based life sciences firm in...
Read MoreRoche to found Institute for Human Biology
Roche has announced that it will be establishing the Institute of Human Biology in Basel. Up to 250 employees will...
Read More